A study to see the role and association of cells of immune system in Endometrial Carcinoma.
Not Applicable
- Conditions
- Health Condition 1: C541- Malignant neoplasm of endometrium
- Registration Number
- CTRI/2020/05/024990
- Lead Sponsor
- Department of Pathology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients above the age of 18 years diagnosed with Endometrial Carcinoma will be considered.
Exclusion Criteria
1. Patients with a past history of Radiotherapy or Chemotherapy for any disease will be excluded from the study.
2. Patients diagnosed with non-epithelial tumours will be excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of infiltration of T lymphocytes, B lymphocytes, macrophages and dendritic cells in Endometrial Carcinomas.Timepoint: Single time
- Secondary Outcome Measures
Name Time Method Association of T lymphocytes, B lymphocytes, macrophages and dendritic cells with clinicopathological parameters.Timepoint: Single time